CN110016455A - A kind of conversion bacterial strain catalyzing and synthesizing Miglitol intermediate and method - Google Patents

A kind of conversion bacterial strain catalyzing and synthesizing Miglitol intermediate and method Download PDF

Info

Publication number
CN110016455A
CN110016455A CN201910160667.0A CN201910160667A CN110016455A CN 110016455 A CN110016455 A CN 110016455A CN 201910160667 A CN201910160667 A CN 201910160667A CN 110016455 A CN110016455 A CN 110016455A
Authority
CN
China
Prior art keywords
bacterial strain
miglitol
strain
sldab
gluconobacter oxydans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910160667.0A
Other languages
Chinese (zh)
Other versions
CN110016455B (en
Inventor
郑裕国
柯霞
余盼红
胡忠策
吴洋
陈亮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang University of Technology ZJUT
Zhejiang Medicine Co Ltd Xinchang Pharmaceutical Factory
Original Assignee
Zhejiang University of Technology ZJUT
Zhejiang Medicine Co Ltd Xinchang Pharmaceutical Factory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University of Technology ZJUT, Zhejiang Medicine Co Ltd Xinchang Pharmaceutical Factory filed Critical Zhejiang University of Technology ZJUT
Priority to CN201910160667.0A priority Critical patent/CN110016455B/en
Publication of CN110016455A publication Critical patent/CN110016455A/en
Application granted granted Critical
Publication of CN110016455B publication Critical patent/CN110016455B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention discloses a kind of conversion bacterial strain for catalyzing and synthesizing Miglitol intermediate and methods, after the conversion bacterial strain is by the inverted recombinant expression plasmid pBBR-sldAB of starting strain ZJB16009, it is obtained again through screening, it is named as gluconobacter oxydans (Gluconobacter oxydans), strain pBBR-sldAB, deposit number is CCTCC No.M 2019033, its N- hydroxyethyl glucosamine dehydrogenase activity has a distinct increment compared with starting strain ZJB16009, and space-time yield is about 2 times of starting strain ZJB16009, show gluconobacter oxydans pBBR-sldAB of the present invention potential using value with higher in the catalyzing and synthesizing of miglitol key intermediate 6NSL.

Description

A kind of conversion bacterial strain catalyzing and synthesizing Miglitol intermediate and method
Technical field
The present invention relates to technical field of bioengineering, more particularly to a kind of conversion for catalyzing and synthesizing Miglitol intermediate Bacterial strain and method.
Background technique
Miglitol [1- (2- ethoxy) -2- (methylol) -3,4,5- piperidines triols, miglitol] is glucose knot Structure analog (as shown in formula I) is a kind of alpha-glycosidase inhibitor class antidiabetic drug of Bayer Bitterfeld GmbH (Bayer) company exploitation Object has high-affinity to amylopsin and alpha-glucosidase, is able to suppress the hydrolysis of disaccharides, polysaccharide and glycoconjugate, prolongs The absorption of slow glucose and other monosaccharide, hypoglycemic effect is obvious, and toxic side effect is significantly lower than sulfonephthalein arteries and veins class and double flesh class drugs, Through one of the critical treatment drug for becoming treatment type-2 diabetes mellitus.
Patent US4246345, US4806650, US5401645 etc. are disclosed using N- hydroxyethyl glucosamine as substrate The process route of student's object combined method synthesis Miglitol is the main technological route of current synthesis Miglitol, and the substrate is by Portugal Grape sugar and ethanol amine are synthesized through a step chemistry hydrogenation process, and it is right to introduce gluconobacter oxydans (Gluconobacter oxydans) Substrate N- hydroxyethyl glucosamine carries out the selective asymmetric oxidation of 4- hydroxyl, and the intermediate product direct-coupling chemistry of acquisition adds Hydrogen Cyclization Miglitol.The more traditional full chemistry synthesis of the technique has synthesis route short, and at low cost, yield is higher Advantage.Wherein, gluconobacter oxydans asymmetry selective oxidation is the critical limitation step of the route.
Although research has the bacterial strain for producing Miglitol intermediate, the especially phase of Gluconobacter oxydans source bacterial strain both at home and abroad Report is closed, such as patent application CN101302549A, CN105968042A, CN104693109A etc., but due to gluconobacter oxydans The biomass of fermentation unit is few, and the vigor of wild strain N- hydroxyethyl glucosamine dehydrogenase is relatively weak, to substrate N- hydroxyl second The tolerance of base gucosamine is poor.Catalysis process is slower, and concentration of substrate and conversion ratio are lower, as used in CN101029321A N- hydroxyethyl glucosamine concentration in 40g/L, limit the production level of Miglitol, need to establish high sorbitol dehydrogenase The bacterial strain of enzyme activity.In addition, the cell fixation or multiple resting cell by gluconobacter oxydans repeatedly apply strategy (CN101270378A) yield of unit cell can be improved to a certain extent, but resting cell is to substrate N- ethoxy Portugal The specific enzyme activity power of the selection dehydrogenation of grapes glucosamine does not significantly improve, single batch substrate feed intake 50g/L and it is following (Hu, ZC., Bu, JL.,Wang,RY.et al.Appl Biochem Biotechnol(2018).https://doi.org/10.1007/ s12010-018-2924-y).Patent CN108441491A is by establishing miglitol key intermediate 6- deoxidation -6- amino (N- Ethoxy)-α-L- furans sorbose (6NSL) fast quantitative measurement method for detecting, combined mutagenesis screening obtains the catalysis of high vigor and closes At Miglitol intermediate 6NSL bacterial strain ZJB16009, concentration of substrate is promoted to 60-80/L, if it is dense to further increase substrate Degree, can significantly reduce the yield of product 6NSL.Early period document report -6 amino of intermediate 6- deoxidation (N- ethoxy)-α-L- furan Mutter sorbose (6NSL) isomerization and its stability can significantly affect Miglitol ultimate yield (J.Org.Chem.2009, 74,1766–1769).Therefore, gluconobacter oxydans are improved to the dehydrogenase activity and full cell of substrate N- hydroxyethyl glucosamine The space-time yield of synthesis key intermediate 6NSL is to promote the Key Strategy of Miglitol bio-conversion process.
Summary of the invention
The present invention is directed to the deficiencies in the prior art, provides one kind and catalyzes and synthesizes the production of Miglitol intermediate space-time The higher conversion bacterial strain of rate, for being catalyzed N- hydroxyethyl glucosamine synthesis -6 amino of 6- deoxidation (N- ethoxy)-α-L- furans Sorbose.
A kind of conversion bacterial strain catalyzing and synthesizing Miglitol intermediate, is named as gluconobacter oxydans (Gluconobacter Oxydans), strain pBBR-sldAB, deposit number are CCTCC No.M 2019033.The oxygen that the bacterial strain is obtained early period by inventor Changing gluconobacter suboxydans, (bacterial strain ZJB16009 (deposit number CCTCC No.M201703), is detailed in Publication No. CN108441491A Patent application), after an inverted recombinant expression plasmid pBBR-sldAB, obtained by screening, wherein recombinantly expressing matter The construction method of grain pBB-sldAB are as follows: by the big small subunit of the sorbitol dehydrogenase of Gluconobacter oxvdans cell membrane localization The coded sequence of SldA (protein sequence accession number ABP65281.1) and SldB (protein sequence accession number ABP65282.1) (No. GenBank is EF493853.1) is inserted into promoter sequence (nucleotide sequence is as shown in SEQ ID No.1) and one A terminator sequence (nucleotide sequence is as shown in SEQ ID No.2) is intermediate, then using restriction site XhoI and EcoRI is inserted into extensive host expression vector pBBR1MCS-5, and building obtains pBBR-sldAB recombinant expression plasmid.Bacterial strain PBBR-sldAB compared with original strain ZJB16009 for, catalyze and synthesize Miglitol intermediate (catalysis N- hydroxyethyl glucosamine Synthesize -6 amino of 6- deoxidation (N- ethoxy)-α-L- furans sorbose) when have higher space-time yield.
Invention further provides the conversion bacterial strains to synthesize -6 amino (N- of 6- deoxidation in catalysis N- hydroxyethyl glucosamine Ethoxy) application in-α-L- furans sorbose.
The present invention also provides a kind of methods for catalyzing and synthesizing Miglitol intermediate using the conversion bacterial strain.
The method, comprising the following steps:
(1) it by the conversion bacterial strain enzymatic production, and collects the thallus after fermentation and obtains resting cell;
(2) product Miglitol is obtained using resting cell catalysis substrate N- hydroxyethyl glucosamine prepared by step (1) Intermediate: -6 amino of 6- deoxidation (N- ethoxy)-α-L- furans sorbose.
Wherein, in step (1) preparation method of resting cell the following steps are included: the conversion bacterial strain is inoculated into culture Fermented and cultured is carried out in base, is then collected thallus and is obtained the resting cell, wherein the culture medium includes: D-glucitol 50g/L, yeast extract powder 25g/L, KH2PO45g/L, K2HPO45g/L, solvent are water.
Preferably, the culture medium further includes sodium glutamate, isoleucine, serine and arginine, and each amino acid makes It is respectively 0.5~5g/L with concentration.
It is furthermore preferred that sodium glutamate 2g/L, isoleucine, serine and each 1g/L of arginine.
Preferably, catalysis reaction is formed using system in step (2) are as follows: 60~120g/ of substrate N- hydroxyethyl glucosamine L, for the resting cell of step (1) preparation with wet thallus 40~80g/L of poidometer, remaining is water.
It is furthermore preferred that catalysis reaction is formed using system in step (2) are as follows: substrate N- hydroxyethyl glucosamine 60g/L, seven Water magnesium sulfate 5g/L, for the resting cell of step (1) preparation with wet thallus poidometer 60g/L, remaining is water, and adjusting pH is 5.0.
Gluconobacter oxydans pBBR-sldAB of the present invention is by the inverted recombinant expression plasmid pBBR- of starting strain ZJB16009 After sldAB, then through screening acquisition, N- hydroxyethyl glucosamine dehydrogenase activity has larger mention compared with starting strain ZJB16009 It rises, and space-time yield is about 2 times of starting strain ZJB16009, it is shown that gluconobacter oxydans pBBR-sldAB of the present invention is in rice Potential using value with higher in the catalyzing and synthesizing of lattice column alcohol key intermediate 6NSL.
Detailed description of the invention
Fig. 1 is that external source adds PQQ to the influence result figure of N- hydroxyethyl glucosamine dehydrogenase activity.
Fig. 2 is that external source adds sodium glutamate to the influence result figure of N- hydroxyethyl glucosamine dehydrogenase activity.
Fig. 3 is that external source adds isoleucine to the influence result figure of N- hydroxyethyl glucosamine dehydrogenase activity.
Fig. 4 is that external source adds serine to the influence result figure of N- hydroxyethyl glucosamine dehydrogenase activity.
Fig. 5 is that external source adds arginine to the influence result figure of N- hydroxyethyl glucosamine dehydrogenase activity.
Specific embodiment
Embodiment 1
Gluconobacter oxydans recombinant bacterium Gluconobacter oxydans pBBR-sldAB (CCTCC No.M 2019033) building.
(1) molecule construction of recombinant expression plasmid pBBR-sldAB:
By the big small subunit SldA of the sorbitol dehydrogenase of Gluconobacter oxvdans cell membrane localization, (protein sequence is logged in Number ABP65281.1) and the coded sequence of SldB (protein sequence accession number ABP65282.1) (No. GenBank is EF493853.1), the substitution of one of them or several nucleotide can cause the substitution of corresponding amino acid residue, to influence N- The function of hydroxyethyl glucosamine dehydrogenase.The coded sequence is inserted into SEQ ID No.1 (promoter sequence) and SEQ ID No.2 (terminator sequence) is intermediate, is inserted into extensive host expression vector using restriction site XhoI and EcoRI In pBBR1MCS-5, building obtains pBBR-sldAB recombinant expression plasmid.
(2) (bacterial strain ZJB16009 (deposit number CCTCC No.M201703), is detailed in Publication No. to Gluconobacter oxvdans The patent application of CN108441491A) electricity turns the preparation of competent cell:
1) saved from 4 DEG C it is flat pull upper picking single colonie and be inoculated in the test tube of the MP culture medium equipped with 5mL, and in 30 DEG C Preculture, until OD600For 0.4-0.6 range;
2) take the preculture bacterium solution of 1mL, access equipped with 50mL EP culture medium (mannitol 80g/L, yeast powder 15g/L, MgSO4·7H2O 2.5g/L, glycerol 0.5g/L, CaCl2In 500mL triangular flask 1.5g/L), 30 DEG C, 200rpm cultivates to bacterium Body OD600For 0.5-0.6 range;
3) triangular flask equipped with bacterium solution is placed in 20min on ice;
4) 4 DEG C, 10min is centrifuged under the conditions of 8000rpm, remove supernatant;
5) the 10% sterile glycerite of 30mL pre-cooling, sufficiently resuspension thallus is added;
6) step 4,5 are repeated twice;
7) 10% glycerite of 1mL pre-cooling, abundant suspension thalline is added, and is dispensed into the 1.5mL EP pipe of oneself sterilizing In, every 100 μ L of pipe is placed in -80 DEG C of refrigerators and saves backup.
(3) Gluconobacter oxvdans is electroporated:
1) it takes the competent cell of above-mentioned preparation to melt on ice, plasmid (pBBR-sldAB recombinant expression plasmid) 5 μ is added L is mixed gently, and stands 30min;
2) it is transferred to the electric revolving cup of pre-cooling, 2000V, 200 Ω, 25 μ F carry out electricity and turn;
3) electric shock terminates the 400 μ L of MP culture medium that pre-cooling is added at once, mixed liquor removal is transferred in 1.5mLEP, 30 DEG C, 200rpm cultivates 4-6h;
4) 200 μ L coated plates are taken, the sorbierite for embracing western fourth sodium and 25ng/mL gentamicin sulphate containing 50ng/mL is coated on On solid plate, 30 DEG C are grown to resistant clones after culture 2-4 days;
5) 4 days are cultivated to visible single colonie for 30 DEG C;
6) bacterium colony PCR is verified, sequence verification, primer sequence are as follows:
Upstream primer: 5 '-CTGGAGGCTTTCACCAAATGCCGAATACTTATGGC-3 ';
Downstream primer: 5 '-TCAGCCCCCGCTTTCTCAGCCCTTGTGATCAGG-3 ';
(4) screening of Gluconobacter oxvdans recon:
The correct positive recombinant of verifying is selected, using quick colour-developing method to the N- hydroxyethyl glucosamine in recon Dehydrogenase activity carries out primary dcreening operation, obtains the recon Gluconobacter oxydans pBBR-sldAB of one plant of higher vigor, It is named as gluconobacter oxydans (Gluconobacter oxydans), strain pBBR-sldAB, is preserved on January 8th, 2019 Positioned at the China typical culture collection center of Wuhan, China Wuhan University, deposit number is CCTCC No.M 2019033.
Embodiment 2
Gluconobacter oxydans Gluconobacter oxydans pBBR-sldAB (CCTCC No.M 2019033) with lure The N- hydroxyethyl glucosamine dehydrogenase activity for becoming bacterial strain ZJB16009 (CCTCC No.M201703) compares.
(1) preparation of gluconobacter oxydans resting cell: by starting strain gluconobacter oxydans mutagenic strain ZJB16009 And the recombinant bacterial strain Gluconobacter oxydans pBBR-sldAB that the present invention constructs is inoculated into equipped with 40mL respectively In the 250mL triangular flask of seed culture fluid, the group of seed culture fluid becomes D-glucitol 50g/L, yeast extract powder 25g/L, KH2PO45g/L, K2HPO45g/L, solvent are water, and pH value is natural (refer to and do not need to adjust pH again).28 DEG C, 235rpm cultivates 48h, Seed liquor is obtained, 10000rpm, 10min are centrifuged, abandons supernatant, clear water washs one time, and supernatant is abandoned in centrifugation, is precipitated as being subsequently used for turning The resting cell of change, resting cell measurement biomass, PQQ supernatant secretion content and N- hydroxyethyl glucosamine dehydrogenation obtained Enzyme activity.Wherein, N- hydroxyethyl glucosamine Dehydrogenase activtity unit of force (U) is defined as under the conditions of 15 DEG C, catalysis substrate per minute N- hydroxyethyl glucosamine generates the enzyme amount of 1.0 μm of oL Miglitol intermediate 6NSL.N- hydroxyethyl glucosamine dehydrogenase Rate activity is that the resting cell N- hydroxyethyl glucosamine dehydrogenase activity of unit biomass is defined as contained by every gram of biomass Enzyme activity unit number (U/g).
Enzyme activity (U/mL)=X × 10 × 103/(M×T)
X:6NSL (g/L)
10: reaction volume (mL)
103: unit conversion
The molal weight (g/mol) of M:6NSL
T: reaction time (h).
The comparison of 1 N- hydroxyethyl glucosamine dehydrogenase activity of table
Analyzed from result above, the N- hydroxyethyl glucosamine dehydrogenase activity of recombinant cell (strain pBBR-sldAB) compared with Starting strain ZJB16009 has a distinct increment, but highest bioaccumulation amount has decline slightly, the ratio consumed from sorbierite Also it can show that the metabolism D-glucitol consumption ratio of recombinant bacterium is obviously improved.
Embodiment 3
Investigate influence of the different aminoacids to fermented and cultured gluconobacter oxydans synthesis sorbitol dehydrogenase.
As it can be seen that although the N- hydroxyethyl glucosamine dehydrogenase activity of recombinant bacterium has is obviously improved from embodiment 2, It is that the content of extracellular coenzyme PQQ is significantly reduced (23.32vs.39.93mg/L) compared with starting strain, prompts limited PQQ Content may inhibit the raising of N- hydroxyethyl glucosamine dehydrogenase activity vigor in cell.In order to verify the hypothesis, pass through The PQQ that various concentration is added in recombinant bacterium culture supernatant measures corresponding dehydrogenase activity.It can be seen from figure 1 that with outer The raising of source PQQ content, corresponding N- hydroxyethyl glucosamine dehydrogenase activity vigor are also significantly increased, it was demonstrated that in recombinant bacterium The rate-limiting step for becoming the realization of N- hydroxyethyl glucosamine dehydrogenase activity of PQQ, the most suitable addition of external source in strain Concentration is 60ng/mL.In order to further promote the PQQ in recombinant bacterium to synthesize, consider to synthesize precusor amino acids from external source addition PQQ Promote its synthesis capability in recombinant bacterium Gluconobacter oxydans pBBR-sldAB.High spot reviews in the present embodiment The addition of different exogenous amino acids is to the vigor of recombinant bacterium N- hydroxyethyl glucosamine dehydrogenase and the influence of PQQ content.It is different The fermentative medium formula of amino acid are as follows: D-glucitol 50g/L, yeast extract 20g/L, KH2PO4 5g/L、K2HPO4 5g/ L, 0.5~5g/L (sodium glutamate, isoleucine, serine and arginine), solvent are deionized water, and pH is natural;Similarity condition Under, not add any amino acid as control.
Embodiment 1 is recombinated 2019033 seed liquor of gluconobacter oxydans CCTCC No.M to be seeded to volumetric concentration 2% Fermentation medium, for 24 hours, fermentation liquid centrifugation, gained thallus is for detecting N- ethoxy grape for fermented and cultured at 28 DEG C, 150rpm The content of osamine dehydrogenase activity and coenzyme PQQ.
N- hydroxyethyl glucosamine dehydrogenase activity detects operating process: take fermentation liquid 20mL to be centrifuged 10000rpm, 10min abandons supernatant, washs one time, and supernatant is abandoned in centrifugation, prepares buffer 100mM PBS, then by 20g/LN- ethoxy glucose Amine and 5g/L epsom salt are dissolved in buffer, adjust pH to 6.0 again, establish the reaction system of 10mL, 28 DEG C of reaction 30min, It samples 1mL centrifugation and carries out conversion ratio and product 6NSL yield that liquid phase tests and analyzes N- hydroxyethyl glucosamine;Liquid phase detector bar Part are as follows: mobile phase is methanol-water (2: 98), 4mM sodium heptanesulfonate+10mM K2HPO4, it is 3.5 with phosphoric acid tune pH value;Flow velocity is 0.5mL/min, sample volume 20μL;30 DEG C of column temperature, time 20min;Calculate product 6NSL yield.
The independent addition pair of PQQ precusor amino acids (sodium glutamate, isoleucine, serine and arginine) is primarily looked at The influence of N- hydroxyethyl glucosamine dehydrogenase activity.From shown in Fig. 2-5, four kinds of amino acid add 0.5~2g/L respectively can Enough raisings for improving N- ethoxy dehydrogenase activity to a certain extent, most suitable addition concentration is respectively sodium glutamate (2g/ L), isoleucine (1g/L), serine (1g/L) and arginine (1g/L), corresponding N- hydroxyethyl glucosamine Dehydrogenase activtity Power is able to ascend 1~20% or so.
The addition of amino acid has further been investigated to the synthesis of coenzyme PQQ and N- hydroxyethyl glucosamine dehydrogenase activity It influences, and under optimum concentration, investigates the shadow of the joint addition to N- hydroxyethyl glucosamine dehydrogenase activity of four kinds of amino acid It rings, the results are shown in Table 2:
The addition of 2 additional amino acid of table is synthesized to PQQ and the promotion of N- hydroxyethyl glucosamine dehydrogenase activity
Interpretation of result: as shown in table 2, different types of amino acid is added into culture medium, after shake flask fermentation culture for 24 hours, Compared to group is not added, unit volume N- hydroxyethyl glucosamine dehydrogenase activity has to be changed to some extent.Wherein, when Non- PQQ synthesis precusor amino acids are added, such as when proline (1g/L), the vigor of N- hydroxyethyl glucosamine dehydrogenase does not almost have It changes;And when adding the synthesis precusor amino acids of coenzyme PQQ, such as 2g/L sodium glutamate, 1g/L isoleucine, 1g/L ammonia Acid and when 1g/L arginine, compared to blank control group, recombinant bacterial strain Gluconobacter oxydans pBBR-sldAB's The content of coenzyme PQQ is significantly increased in culture supernatant;Corresponding, the vigor of N- hydroxyethyl glucosamine dehydrogenase is also significant It improves, and positive correlation is presented in the raising ratio of the two.It is worth noting that, after four kinds of precusor amino acids are added simultaneously, PQQ Exocytosis content reach 44.43 ± 1.78mg/L of peak, the vigor of N- hydroxyethyl glucosamine dehydrogenase also reaches most 676.5 ± 25.6U/L of high level, the vigor is suitable with the N- ethoxy enzyme activity that the PQQ of external source addition 60ng/mL is promoted, but It is to effectively reduce fermentation costs.The above results show that by before the synthesis of additionally adding coenzyme PQQ in conventional medium Body can promote biosynthesis and exocytosis of the recombinant bacterial strain Gluconobacter oxydans pBBR-sldAB to PQQ, To further improve the vigor of N- hydroxyethyl glucosamine dehydrogenase, the dehydrogenase activity of unit volume is compared with control medium Improve 20% or more.
Embodiment 4
G.oxydans pBBR-sldAB resting cell catalyzes and synthesizes 6NSL under different concentration of substrate.
Transformation system: having flask with indentation 50mL/500mL, prepares N- hydroxyethyl glucosamine and (is first adjusted to meta-acid with dense HCl Condition, then being adjusted to 5.0, N- hydroxyethyl glucosamine concentration with 2M NaOH is respectively 60,80,100 and 120g/L;MgSO4· 7H2O final concentration 5g/L adds the wet bacterium of resting cell that G.oxydanspBBR-sldAB fermented and cultured obtains in 3 method of embodiment The additive amount of body, wet thallus is 60g/L, is constituted 50mL reaction system by reaction medium of deionized water.
Experiment condition: temperature: 15 DEG C;Revolving speed: 220rpm;Every 12h 2M NaOH alkali tune, maintains the pH value of conversion fluid 4.5~5.0.
Sampling: every 12h sampling, centrifuging and taking supernatant, liquid phase test sample yield, thallus microscopy.
Interpretation of result: the substrate transformation rate and efficiency of pcr product under the conditions of different concentration of substrate have been investigated, as a result such as 3 institute of table Show, under different concentration of substrate, the substrate transformation rate reaches 97% or more;Efficiency of pcr product is analyzed, substrate 60g/L, 80g/L, Efficiency of pcr product can achieve 90% or so when 100g/L, and when concentration of substrate is promoted to 120g/L, efficiency of pcr product is significantly reduced, and be 71.17%.Comprehensively consider, most suitable concentration of substrate selects 100g/L, yield 88.04%.
Resting cell catalyzes and synthesizes 6NSL in flask system under the different concentration of substrate of table 3
Embodiment 5
Influence of the different G.oxydans pBBR-sldAB resting cell throwing amounts to 6NSL is catalyzed and synthesized.
Transformation system: having flask with indentation 50mL/500mL, prepares N- hydroxyethyl glucosamine and (is first adjusted to meta-acid with dense HCl Condition, then being adjusted to 5.0, N- hydroxyethyl glucosamine concentration with 2M NaOH is respectively 100g/L;MgSO4·7H2O final concentration 5g/ L, according in 3 method of embodiment G.oxydans pBBR-sldAB fermented and cultured obtain resting cell wet thallus, wet thallus Additive amount is 40,60,80g/L, is constituted 50mL reaction system by reaction medium of deionized water.
Experiment condition: temperature: 15 DEG C;Revolving speed: 220rpm;Every 12h 2M NaOH alkali tune, maintains the pH value of conversion fluid 4.5~5.0.
Sampling: every 12h sampling, centrifuging and taking supernatant, liquid phase test sample yield, thallus microscopy.
Interpretation of result: under the conditions of having investigated 100g/L concentration of substrate, the additive amount of different catalysts is timely to reaction process The influence of empty yield is significant.The results are shown in Table 4, with the raising of catalyst amount, the reaction time needed for 100g/L substrate Significant to shorten, when cell throwing amount is more than or equal to 60g/L wet cell concentration, the substrate transformation rate reaches 90% or more;Efficiency of pcr product 88% or more, when cell throwing amount is 80g/L, 6NSL cumulative concentration reaches 92.4g/L, space-time yield 110.88gproduct L-1d-1.Overall cost considers that optimal cell throwing amount is 60g wet cell/L.
Influence of the 4 different catalysts throwing amount of table to 6NSL space-time yield is catalyzed and synthesized
Embodiment 6
Recombinant bacterial strain Gluconobacter oxydans pBBR-sldAB and gluconobacter oxydans mutagenic strain ZJB16009 catalyzes and synthesizes Miglitol intermediate 6NSL ability and compares.
(1) preparation of gluconobacter oxydans resting cell: by starting strain gluconobacter oxydans mutagenic strain ZJB16009 And recombinant bacterial strain Gluconobacter oxydans pBBR-sldAB carries out enzymatic production (with embodiment 2), and 28 DEG C, 235rpm After fermented and cultured 18h, the fermentation liquid 20mL containing wet thallus is obtained, is centrifuged 10000rpm, 10min, abandons supernatant, clear water washing one Time, supernatant is abandoned in centrifugation, is precipitated as being subsequently used for the resting cell of conversion.
(2) foundation and catalysis of catalysis substrate N- hydroxyethyl glucosamine synthesis Miglitol intermediate 6NSL transformation system Process compares:
Reaction system: substrate N- hydroxyethyl glucosamine 100g/L, resting cell wet thallus concentration be 60g/L, with go from Sub- water is reaction medium, and saturation HCl adjusts pH to 5.0, establishes 50mL reaction system, rear for 24 hours whole in 15 DEG C of progress conversion reactions It only reacts, detects the cumulative concentration of product 6NSL, liquid phase testing conditions are same
Embodiment 1.
The key parameter of 5 two plants of bacterium catalysis substrate N- hydroxyethyl glucosamine synthesis 6NSL of table compares
As shown in table 5, under 100g/L concentration of substrate, recombinant bacterial strain G.oxydans pBBR-sldAB catalyzes and synthesizes 6NSL Efficiency be significantly higher than starting strain ZJB-16009.After reaction for 24 hours, the conversion of concentration of substrate 100g/L can be realized substantially, and And the yield of product 6NSL is significantly higher than control strain (86.8% and 71.4%), and the transformation period shortens 12h.Further meter Space-time yield is calculated, the space-time yield of recombinant bacterium is about 2 times of control strain, it is shown that recombinant bacterium G.oxydans pBBR-sldAB Potential using value in the catalyzing and synthesizing of miglitol key intermediate 6NSL.
Sequence table
<110>Zhejiang Polytechnical University
Zhejiang Medicine Co
<120>a kind of conversion bacterial strain for catalyzing and synthesizing Miglitol intermediate and method
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 133
<212> DNA
<213>gluconobacter oxydans (Gluconobacter oxydans)
<400> 1
tgaaagcggc tggcgcgtgc tggcggggct gtaacagaac tgcaaaaccg gaacgctgag 60
aaagttggta acatcccact ttttcagggt ataacgcctt ccgcggactt tcagttctgg 120
aggctttcac caa 133
<210> 2
<211> 115
<212> DNA
<213>gluconobacter oxydans (Gluconobacter oxydans)
<400> 2
gaaagcgggg gctgaggccg ccgggtgatg gaaggggtgg ttttcgtgct gcaaatggca 60
cggagaccgc ccctttgtcg tttccggggc cgttttttcc atttttcggg tggga 115
<210> 3
<211> 35
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 3
ctggaggctt tcaccaaatg ccgaatactt atggc 35
<210> 4
<211> 33
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 4
tcagcccccg ctttctcagc ccttgtgatc agg 33

Claims (9)

1. a kind of conversion bacterial strain for catalyzing and synthesizing Miglitol intermediate, which is characterized in that be named as gluconobacter oxydans (Gluconobacter oxydans), strain pBBR-sldAB, deposit number are CCTCC No.M2019033.
2. conversion bacterial strain synthesizes -6 amino of 6- deoxidation (N- hydroxyl second in catalysis N- hydroxyethyl glucosamine as described in claim 1 Base) application in-α-L- furans sorbose.
3. a kind of use the method that conversion bacterial strain catalyzes and synthesizes Miglitol intermediate as described in claim 1.
4. method as claimed in claim 3, which comprises the following steps:
(1) bacterial strain enzymatic production will be converted as described in claim 1, and be collected the thallus after fermentation and obtained resting cell;
(2) it is obtained among product Miglitol using resting cell catalysis substrate N- hydroxyethyl glucosamine prepared by step (1) Body: -6 amino of 6- deoxidation (N- ethoxy)-α-L- furans sorbose.
5. method as claimed in claim 4, which is characterized in that the preparation method of resting cell includes following step in step (1) It is rapid: conversion bacterial strain as described in claim 1 being inoculated into culture medium and carries out fermented and cultured, it is described quiet then to collect thallus acquisition Cease cell, wherein the culture medium includes: D-glucitol 50g/L, yeast extract powder 25g/L, KH2PO45g/L, K2HPO4 5g/L, solvent are water.
6. method as claimed in claim 5, which is characterized in that the culture medium further includes sodium glutamate, isoleucine, silk ammonia Acid and arginine, the use concentration of each amino acid is respectively 0.5~5g/L.
7. method as claimed in claim 6, which is characterized in that sodium glutamate 2g/L, isoleucine, serine and arginine are each 1g/L。
8. method as claimed in claim 4, which is characterized in that catalysis reaction is formed using system in step (2) are as follows: substrate N- 60~120g/L of hydroxyethyl glucosamine, with wet thallus 40~80g/L of poidometer, remaining is the resting cell of step (1) preparation Water.
9. method according to claim 8, which is characterized in that catalysis reaction is formed using system in step (2) are as follows: substrate N- Hydroxyethyl glucosamine 100g/L, epsom salt 5g/L, the resting cell of step (1) preparation with wet thallus poidometer 60g/L, Remaining is water, and adjusting pH is 5.0.
CN201910160667.0A 2019-03-04 2019-03-04 Transformation strain and method for catalytically synthesizing miglitol intermediate Active CN110016455B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910160667.0A CN110016455B (en) 2019-03-04 2019-03-04 Transformation strain and method for catalytically synthesizing miglitol intermediate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910160667.0A CN110016455B (en) 2019-03-04 2019-03-04 Transformation strain and method for catalytically synthesizing miglitol intermediate

Publications (2)

Publication Number Publication Date
CN110016455A true CN110016455A (en) 2019-07-16
CN110016455B CN110016455B (en) 2021-07-27

Family

ID=67189262

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910160667.0A Active CN110016455B (en) 2019-03-04 2019-03-04 Transformation strain and method for catalytically synthesizing miglitol intermediate

Country Status (1)

Country Link
CN (1) CN110016455B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112592879A (en) * 2020-12-31 2021-04-02 浙江工业大学 Recombinant Gluconobacter oxydans engineering bacterium and application thereof in synthesizing miglitol intermediate

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108456665A (en) * 2018-02-01 2018-08-28 浙江工业大学 A method of promoting gluconobacter oxydans synthesis sorbitol dehydrogenase and coenzyme pyrroloquinoline quinone

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108456665A (en) * 2018-02-01 2018-08-28 浙江工业大学 A method of promoting gluconobacter oxydans synthesis sorbitol dehydrogenase and coenzyme pyrroloquinoline quinone

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
XIA KE等: "Biosynthesis of miglitol intermediate 6-(N-hydroxyethyl)-amino-6-deoxy-α-l-sorbofuranose by an improved d-sorbitol dehydrogenase from Gluconobacter oxydans", 《3 BIOTECH》 *
XUE-PENG YANG等: "Membrane-Bound Pyrroloquinoline Quinone-Dependent Dehydrogenase in Gluconobacter oxydans M5, Responsible for Production of 6-(2-Hydroxyethyl) Amino-6-Deoxy-L-Sorbose", 《APPLIED AND ENVIRONMENTAL MICROBIOLOGY》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112592879A (en) * 2020-12-31 2021-04-02 浙江工业大学 Recombinant Gluconobacter oxydans engineering bacterium and application thereof in synthesizing miglitol intermediate

Also Published As

Publication number Publication date
CN110016455B (en) 2021-07-27

Similar Documents

Publication Publication Date Title
US11753658B2 (en) Pichia stipitis strain and cultures and uses of the same
CN108102995B (en) D-psicose 3-epimerase production strain and immobilization method thereof
Sheng et al. Direct hydrogen production from lignocellulose by the newly isolated Thermoanaerobacterium thermosaccharolyticum strain DD32
CN103468624B (en) Genetic engineering bacteria used for high efficient production of mycose
CN102392056A (en) Genetically engineered strain and method for producing dihydroxyacetone by using the same
CN109609525A (en) Grifola frondosus glucan synthase, its encoding gene and application
CN104046586B (en) One strain gene engineering bacterium and the application in producing (2R, 3R)-2,3-butanediol thereof
CN113416761B (en) Method for preparing NMN by fermentation culture method
CN110016455A (en) A kind of conversion bacterial strain catalyzing and synthesizing Miglitol intermediate and method
CN107058414B (en) Method for preparing L-alanine
CN111218486A (en) Process for synthesizing lactobionic acid by biological method
WO2008120233A1 (en) A process for the preparation of ethanol from starch
CN111484942A (en) Method for producing adipic acid by using saccharomyces cerevisiae
CN104830744A (en) Method for preparing (R)-phenylglycol from SD-AS sequence coupled (R)-carbonyl reductase and glucose dehydrogenase
CN115141841A (en) Pichia pastoris mutant strain and application thereof in production of alginate lyase
CN109161570B (en) Method for improving fermentation production of N-acetylneuraminic acid and fermentation liquor
CN104789489A (en) Arginine deiminase high-yielding Bacillus cereus and application thereof
CN104480164A (en) Enzymic method for preparing lactosucrose
CN113151132B (en) Gluconobacter oxydans genetically engineered bacterium for producing 5-ketofructose, construction method and application thereof
CN110982767B (en) Cell fusion strain and application thereof
CN114480359B (en) Method for producing psicose 3-epimerase by high-density fermentation
CN114181859B (en) Geobacillus stearothermophilus and method for producing lactic acid by using lignocellulose
CN109971817B (en) Preparation of baodanone by sequential transformation of Arthrobacter simplex and genetically engineered yeast strain
RU2186850C2 (en) Method of citric acid producing
CN117305144A (en) Recombinant pichia pastoris, construction method thereof and application thereof in production of L-lactic acid

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant